Introduction Confluence Pharmaceuticals is a company that focuses on creating innovative medications to treat neurological developmental disorders. These disorders include fragile X syndrome and autism spectrum disorders, which can cause social and communication impairments. The company was established by Steven L. Johns, Craig A. Erickson, and Boyd W. Sturdevant, Jr. and is based in Indianapolis, IN. |